As observed in in vitro studies using HCC cells (see above in Section 3.2), administration with an AKT inhibitor, MK2206, led to the growth inhibition of tumors in xenograft models transplanted with Hep3B and Huh7 [50]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.